MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NxStage Medical Company Profile (NASDAQ:NXTM)

Consensus Ratings for NxStage Medical (NASDAQ:NXTM) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.00 (64.91% upside)

Analysts' Ratings History for NxStage Medical (NASDAQ:NXTM)
Show:
DateFirmActionRatingPrice TargetActions
2/11/2016Piper JaffrayReiterated RatingOverweight$24.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016BTIG ResearchReiterated RatingBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Canaccord GenuityReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015BTIG ResearchInitiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2015Sterne Agee CRTInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Leerink SwannBoost Price Target$24.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Canaccord GenuityReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2015Leerink SwannReiterated RatingOutperform$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Canaccord GenuityReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Canaccord GenuityBoost Price TargetBuy$24.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2014Canaccord GenuityReiterated RatingBuy$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Piper JaffrayBoost Price Target$16.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Canaccord GenuityBoost Price TargetBuy$19.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Canaccord GenuityReiterated RatingBuy$21.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2014Wells FargoDowngradeMarket Perform -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/28/2014Jefferies GroupBoost Price Target$13.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014Leerink SwannBoost Price Target$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014Canaccord GenuityBoost Price Target$18.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/11/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha